Taking action on nitrous oxide
Nitrous oxide has legitimate uses in the food industry and this makes its misuse difficult to combat, but proper checks at the time of purchase could reduce the… read more.
Nitrous oxide has legitimate uses in the food industry and this makes its misuse difficult to combat, but proper checks at the time of purchase could reduce the… read more.
Here’s a scenario so common that it applies to nearly 92 percent of older adults with cancer: An individual comes in for treatment and reports taking several medications… read more.
Nitrous oxide abuse appears to be widespread but it is far from harmless and prolonged use can lead to paralysis. Pharmacists need to raise awareness of the potentially… read more.
Professor Gino Martini was recently appointed as the Chief Executive of the Precision Health Technologies Accelerator (PHTA) at Birmingham University. Previously he was Chief Scientist at the Royal… read more.
Leicester researchers are working with NHS partners in the East of England to lead the way in delivering the NHS’ goal of halving the amount of opioids prescribed… read more.
While most of us were baking sourdough bread and watching “Tiger King” to stay sane during the pandemic shutdown, UC Riverside bioengineering professor William Grover kept busy counting… read more.
Anyone who is taking a diuretic and a renin-angiotensin system (RSA) inhibitor for high blood pressure should be cautious about also taking ibuprofen, according to new research. Diuretics… read more.
In a questionnaire-based study published in Pharmacology Research & Perspectives that included 485 fully trained nurses of 107 home care services, nearly half of all nursing staff made at least… read more.
The European Medicine Agency’s key expert body – the Committee for Medicinal Products for Human Use (CHMP) – has recommended that four medicines be approved in the EU…. read more.
Two established diabetes medicines have been given the green light for use outside the EU – even when stored at higher temperatures – under the EU Medicines for… read more.
Amgen announced results from a pooled post-hoc analysis of the pivotal NAVIGATOR Phase III and PATHWAY Phase IIb trials showed Tezspire (tezepelumab-ekko) demonstrated reductions in the annualized asthma… read more.
Microfluidic devices are compact testing tools made up of tiny channels carved on a chip, which allow biomedical researchers to test the properties of liquids, particles and cells… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.